Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants
Clinical trial NCT05026996 · COMPLETED
Trial details
- NCT number
- NCT05026996
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2022-10-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.